Results 61 to 70 of about 256,425 (387)

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Biomedicines, 2021
Secondary prevention of peripheral arterial disease (PAD) includes administration of antiplatelet agents, and adherence to medication is a requirement for an effective treatment.
Martin Wawruch, Jan Murin, Tomas Tesar, Martina Paduchova, Miriam Petrova, Denisa Celovska, Petra Matalova, Beata Havelkova, Michal Trnka, Emma Aarnio   +9 more
doaj   +1 more source

Real-practice thromboprophylaxis in atrial fibrillation [PDF]

, 2017
This retrospective observational study was based on databases of the Local Health Authority of Treviso, Italy. It evaluated the prevalence and the effectiveness of oral anticoagulation treatment (OAT) for the management of nonvalvular atrial fibrillation
Bettiol, Alessandra, Bolcato, Jenny, Chinellato, Alessandro, Deambrosis, Paola, Franchin, Giulia, Giusti, Pietro, Pellizzari, Michele, Pirolo, Roberta, Themistoclakis, Sakis   +8 more
core   +2 more sources

Antioxidant Capacity and Antiplatelet Activity of Aqueous Extracts of Common Bean (Phaseolus vulgaris L.) Obtained with Microwave and Ultrasound Assisted Extraction

Plants, 2022
Phaseolus vulgaris L. has beneficial effects on several chronic non-communicable diseases (e.g., cardiovascular diseases) related to oxidative stress.
Lyanne Rodríguez, Andrea Plaza, Diego Méndez, Basilio Carrasco, Francisca Tellería, Iván Palomo, Eduardo Fuentes   +6 more
doaj   +1 more source

A hopeful therapy for Niemann-Pick C diseases [PDF]

, 2017
Not abstract ...
Erickson, Robert P., Fiorenza, Maria Teresa   +1 more
core   +1 more source

Atractylodes lactone compounds inhibit platelet activation

Platelets, 2017
Platelets play a crucial role in the development and progression of atherosclerosis-thrombosis and, therefore, antiplatelet drugs are widely used in the treatment of coronary artery disease. Moreover, advances in understanding the biological functions of
Yizhu Chen, Wenlong Yang, Lingyu Guo, Xiaolin Wu, Tiantian Zhang, Junling Liu, Junfeng Zhang   +6 more
doaj   +1 more source

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage

JAMA Neurology, 2021
Key Points Question What are the long-term effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage in patients who were in the pilot phase of the Restart or Stop Antithrombotics Randomized Trial?
R. Al‐Shahi Salman, M. Dennis, P. Sandercock, C. Sudlow, J. Wardlaw, W. Whiteley, G. Murray, J. Stephen, Aryelly Rodriguez, S. Lewis, D. Werring, P. White   +11 more
semanticscholar   +1 more source

Identification of a New Morpholine Scaffold as a P2Y12 Receptor Antagonist

Molecules, 2016
The P2Y12 receptor is critical for platelet activation and is an attractive drug target for the prevention of atherothrombotic events. Despite the proven antithrombotic efficacy of P2Y12 inhibitors, these thienopyridine scaffolds are prodrugs that lack ...
Young Ha Ahn, Joo-Youn Lee, Hee Dong Park, Tae Hun Kim, Min Chul Park, Gildon Choi, Sunghoon Kim   +6 more
doaj   +1 more source

Can Isoquinoline Alkaloids Affect Platelet Aggregation in Whole Human Blood?

Toxins, 2022
Isoquinoline alkaloids have multiple biological activities, which might be associated with positive pharmacological effects as well as negative adverse reactions.
Mst Shamima Parvin, Marcel Hrubša, Jaka Fadraersada, Alejandro Carazo, Jana Karlíčková, Lucie Cahlíková, Jakub Chlebek, Kateřina Macáková, Přemysl Mladěnka   +8 more
doaj   +1 more source

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Российский кардиологический журнал, 2021
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment ...
J.-P. Collet, H. Thiele, E. Barbato, O. Barthélémy, J. Bauersachs, D. L. Bhatt, P. Dendale, M. Dorobantu, T. Edvardsen, T. Folliguet, Ch. P. Gale, M. Gilard, A. Jobs, P. Jüni, E. Lambrinou, B. S. Lewis, Ju. Mehilli, E. Meliga, B. Merkely, O. Mueller, M. Roffi, F. H. Rutten, D. Sibbing, G. C.M. Siontis   +23 more
doaj   +1 more source

Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry [PDF]

, 2016
Background: Recent evidence supports that most non-lacunar cryptogenic strokes are embolic. Accordingly, these strokes have been designated as embolic strokes of undetermined source (ESUS).
Ameriso, Sebastian F, Arauz, Antonio, Berkowitz, Scott D, Bosch, Jackie, Brouns, Raf, Connolly, Stuart J, Coutinho, Jonathan, Cunha, Luis, Gagliardi, Rubens J, Giruparajah, Mohana, Hankey, Graeme J, Hart, Robert G, Kasner, Scott E, Kitagawa, Kazuo, Lavallee, Philippa, Mattina, Katie R, Muir, Keith, O\u2019Donnell, Martin J, Perera, Kanjana S, Pieroni, Alessio, Shamalov, Nikolay, Swaminathan, Balakumar, Vanassche, Thomas, Vastagh, Ildiko, Vermehren, Philipp, Wang, Yongjun, Yoon, Byung-Woo, Yperzeele, Laetitia   +27 more
core   +2 more sources